Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Prosight Management, LP
Form 13F · Q2 2026

Prosight Management, LP

CIK 1617201Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$580M
Reported book value
36
Positions
12
Quarters on record
Top 50
Positions

Prosight Management, LP — holdings

Top 36 positions of 36, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1LKFT Lakefront Biotherapeutics2.0M+31.8%$61M10.6%
2JANX Janux Therapeutics Inc3.8M+7.2%$58M10.1%
3NKTR Nektar Therapeutics810,000+10.2%$57M9.7%
4BSX Boston Scientific Corp1.3M+59.7%$54M9.3%
5STTK Shattuck Labs Inc6.0M+19.1%$41M7.1%
6INSM Insmed Inc375,609—$40M6.9%
7ALNY Alnylam Pharmaceuticals Inc98,080+29.1%$30M5.1%
8SNDX Syndax Pharmaceuticals Inc1.2M+55.8%$26M4.5%
9KURA Kura Oncology Inc2.0M−39.8%$22M3.8%
10ALKS Alkermes Plc394,389−23.2%$21M3.6%
11IRTC Irhythm Holdings Inc165,500+1555.0%$20M3.4%
12VEEV Veeva Sys Inc106,200+22.8%$19M3.2%
13ZYME Zymeworks Inc674,434+25.1%$18M3.0%
14ABIVAX SA Abivax Sa107,394+2.3%$14M2.5%
15CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In374,666+7.0%$14M2.4%
16MLYS Mineralys Therapeutics Inc449,795—$12M2.1%
17ADCT Adc Therapeutics Sa7.8M−5.7%$8M1.4%
18ICU MED INC Icu Med Inc51,000+85.8%$7M1.3%
19ISRG Intuitive Surgical Inc17,000+325.0%$7M1.2%
20CRBP Corbus Pharmaceuticals Hldgs650,000−6.8%$6M1.1%
21PRCT Procept Biorobotics Corp268,269−86.2%$6M1.0%
22WGS Genedx Holdings Corp85,500−83.7%$6M1.0%
23OPCH Option Care Health Inc270,716—$6M1.0%
24OKUR Onkure Therapeutics Inc978,992−54.6%$4M0.8%
25EBS Emergent Biosolutions Inc459,952−28.0%$4M0.7%
26PFE Pfizer Inc135,366—$3M0.6%
27KIDS Orthopediatrics Corp157,500−47.9%$3M0.5%
28RCKT Rocket Pharmaceuticals Inc700,000+2.4%$2M0.4%
29ANTX An2 Therapeutics Inc474,638−8.0%$2M0.4%
30PLRX Pliant Therapeutics Inc1.4M−17.8%$2M0.3%
31TECX Tectonic Therapeutic Inc39,731−50.3%$1M0.2%
32MGTX Meiragtx Hldgs Plc90,000−96.6%$1M0.2%
33EFOR Everforth Inc67,500—$1M0.2%
34RNTX Rein Therapeutics Inc1.1M+167.2%$1M0.2%
35COYA Coya Therapeutics Inc170,000−59.6%$994,5000.2%
36IMRX Immuneering Corp36,861−70.1%$183,9360.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.